Skip to main content
ISTH 2023 Main banner
Back

    Francis Couturaud, PhD (he/him/his)

    MD, PhD
    Centre Hospitalo-Universitaire de Brest, Département de Médecine Interne et Pneumologie, INSERM U1304, CIC INSERM 1412, Univ_Brest, Brest, FCRIN INNOVTE, France.
    Brest, Bretagne, France

    Francis Couturaud is currently Clinical Professor of Respiratory Medicine at Brest University and Head of Department of Respiratory Medicine at Brest University Hospital Center in Brest, France.
    He is the director of the research unit INSERM “U1304-GETBO”, dedicated to clinical research and basic science in venous thromboembolism.
    He is the director of the French INvestigation Network On Venous Thrombo-Embolism (INNOVTE), a labellised F-CRIN network promoting translational clinical research and European clinical studies on venous thromboembolism.
    He is also council member of the International Network of VENous Thromboembolism (INVENT), which includes 12 countries, dedicated on clinical trials in venous thromboembolism.
    Dr Couturaud is involved in clinical research on the pathophysiology, diagnosis, epidemiology and treatment of pulmonary embolism. He has been involved in many studies on pulmonary embolism published in major journals, especially the PADIS-PE, PADIS-DVT, PEITHO, PREPIC-2, MVTEP trials.
    The optimal duration of anticoagulation in patients with venous thromboembolism, particularly in cases of unprovoked venous thromboembolism, is one of his main fields of interest. He is currently conducting the RENOVE trial, a large multicenter randomized controlled trial comparing long term direct oral anticoagulant therapy at full dose versus low dose in patients with venous thromboembolism at high risk of recurrence.

    Presentation(s):